KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Amortization - Intangibles: 2018-2025

Historic Amortization - Intangibles for Adaptive Biotechnologies (ADPT) over the last 8 years, with Sep 2025 value amounting to $428,000.

  • Adaptive Biotechnologies' Amortization - Intangibles changed negligibly% to $428,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 0.35%. This contributed to the annual value of $1.7 million for FY2024, which is 0.24% up from last year.
  • Per Adaptive Biotechnologies' latest filing, its Amortization - Intangibles stood at $428,000 for Q3 2025, which was up 1.18% from $423,000 recorded in Q2 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Amortization - Intangibles peaked at $429,000 during Q4 2021, and registered a low of $419,000 during Q1 2021.
  • In the last 3 years, Adaptive Biotechnologies' Amortization - Intangibles had a median value of $424,000 in 2024 and averaged $424,727.
  • In the last 5 years, Adaptive Biotechnologies' Amortization - Intangibles fell by 1.18% in 2021 and then increased by 0.95% in 2024.
  • Adaptive Biotechnologies' Amortization - Intangibles (Quarterly) stood at $429,000 in 2021, then remained steady at $429,000 in 2022, then remained steady at $429,000 in 2023, then dropped by 0.23% to $428,000 in 2024, then remained steady at $428,000 in 2025.
  • Its last three reported values are $428,000 in Q3 2025, $423,000 for Q2 2025, and $419,000 during Q1 2025.